ArticleNaunyn-Schmiedeberg's archives of pharmacology2012

Rilmenidine improves hepatic steatosis through p38-dependent pathway to higher the expression of farnesoid X receptor.

Po-Sheng Yang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.